BEAM - Beam extends slide as Leerink downgrades on restructuring plans
2023-10-20 12:45:56 ET
More on Beam Therapeutics
- Beam Therapeutics: Rich In Cash, Poor In Punctuality (Rating Downgrade)
- Beam Therapeutics: Awaiting Clinical Progress And Path Towards Profitability
- Beam Therapeutics to cut 20% of workforce; sees cash runway into 2026
- Seeking Alpha’s Quant Rating on Beam Therapeutics
- Historical earnings data for Beam Therapeutics
For further details see:
Beam extends slide as Leerink downgrades on restructuring plans